Yahoo! FinanceHome - Yahoo! - Help

Market Guide

[ Stock Screener | Company & Fund Index | Financial Glossary ]

Profile - Transgene (NasdaqNM:TRGNY)
As of 31-Aug-2001
Enter symbol:
symbol lookup

 
More Info: Quote | Chart | News | Profile | Msgs
Location
11 rue de MOLSHEIM, 67082 STRASBOURG
Cedex, France
Phone: (212) 696-4455
Fax: (212) 696-9180
Email: communication@transgene.fr
Employees (last reported count): 197
Financial Links
 ·Top Institutional Holders
 ·Top Mutual Fund Holders
 ·Historical Quote Data
 ·Raw SEC Filings at sec.gov
Competitors:
 ·Sector: Healthcare
 ·Industry: Biotechnology & Drugs
Company Websites
 ·Home Page
 ·Investor Relations
 ·Employment
 ·Yahoo! Category

 ·Search Yahoo! for related links...

Ownership
·Insider and 5%+ Owners: 64%
·Institutional: 6% (15% of float)
(9 institutions)
·Net Inst. Selling: 342.0K shares (+53.87%)
(prior quarter to latest quarter)
More From Market Guide
 ·Highlights
 ·Performance
 ·Ratio Comparisons
Business Summary
Transgene SA is dedicated to the discovery and development of gene therapy products and technologies for the treatment of acquired and inherited diseases. The Company has multiple, proprietary vector platforms, which include adenoviral, vaccinia viral, retroviral, cellular and synthetic vectors. The Company offers multiple, differentiated vector technologies for gene delivery, each customized for different clinical situations. Transgene is using its proprietary vector technology to create a broad pipeline of potential products in cancer, cardiovascular and hereditary diseases.
More from Market Guide: Expanded Business Description

Financial Summary
Transgene is an integrated biotechnology company dedicated to the discovery and development of gene therapy technologies and products for the treatment of acquired or inherited diseases for which there is no cure or adequate therapy. For the six months ended 6/01, revenues fell 68% to EUR775K. Net loss rose 7% to EUR11.1 million. Revenues reflect decreased grants received for R and D. Higher loss was partially offset by lower S/G/A costs as a % of revenue.

Recent Earnings Announcement
For the 3 months ended 06/30/2001, revenues were 169; after tax earnings were -5,528. (Preliminary; reported in thousands of Euro.)

More from Market Guide: Significant Developments

Officers

Position
Alain Merieux, 61Chiarman of the Board
Gilles BelangerCEO
Margaret Liu, M.D.Vice Chairman
Paul BikardCFO
Jean-Francois Carmier, 41Exec. VP, Pharmaceutical Devel.
More from Market Guide on Officers & Directors:
Expanded List, Bios, Compensation, Options
Statistics at a Glance -- NasdaqNM:TRGNYAs of 31-Aug-2001
Price and Volume
52-Week Low
on 17-July-2001
$2.00 
Recent Price$2.45 
52-Week High
on 1-Sep-2000
$18.594
Beta0.13 
Daily Volume (3-month avg)4,227 
Daily Volume (10-day avg)1,000 
Stock Performance
[one-year price graph]
big chart [1d | 5d | 3m | 6m | 1y | 2y | 5y]
52-Week Change-86.5%
52-Week Change
relative to S&P500
-81.9%
Share-Related Items
Market Capitalization$43.4M
Shares Outstanding17.7M
Float6.36M
Dividends & Splits
Annual Dividendnone 
Last Splitnone 
Per-Share Data
Book Value (mrq*)$1.51 
Earnings (ttm)-$1.13 
Earnings (mrq)-$0.22 
Sales (ttm)$0.15 
Cash (mrq*)$1.28 
Valuation Ratios
Price/Book (mrq*)1.62 
Price/EarningsN/A 
Price/Sales (ttm)16.73 
Income Statements
Sales (ttm)$2.78M
EBITDA (ttm*)-$21.4M
Income available to common (ttm)-$21.1M
Profitability
Profit MarginN/A 
Operating MarginN/A 
Fiscal Year
Fiscal Year EndsDec 31
Most recent quarter
(fully updated)
31-Mar-2001
Most recent quarter
(flash earnings)
30-June-2001
Management Effectiveness
Return on Assets (ttm)-46.29%
Return on Equity (ttm)-61.72%
Financial Strength
Current Ratio (mrq*)5.23 
Debt/Equity (mrq*)0 
Total Cash (mrq)$83.9M
Short Interest
As of 8-Aug-2001
Shares Short10.0K
Percent of Float0.2%
Shares Short
(Prior Month)
30.0K
Short Ratio3.33 
Daily Volume3,000 
ADR Information
Shares/ADR0.33
See Profile Help for a description of each item above;   K = thousands;   M = millions;   mrq = most-recent quarter;   ttm = trailing twelve months;   (as of 30-June-2001, except mrq*/ttm* items as of 31-Mar-2001);   dollar amounts based on an exchange rate of 1.1 Euro/Dollar

Market Guide offers more in-depth Company Research, Stock Screening, and Hottest Stocks and Industries on over 10,000 U.S. Equities.


Copyright © 2001 Yahoo! Inc. All Rights Reserved. Privacy Policy - Terms of Service
Company information Copyright Market Guide. Historical chart data and daily updates provided by Commodity Systems, Inc. (CSI). Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers (such as Market Guide, CSI, etc.) shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon.